<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34403832</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1567-7257</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><PubDate><Year>2021</Year><Month>11</Month></PubDate></JournalIssue><Title>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</Title><ISOAbbreviation>Infect Genet Evol</ISOAbbreviation></Journal><ArticleTitle>Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2.</ArticleTitle><Pagination><MedlinePgn>105038</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1567-1348(21)00336-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.meegid.2021.105038</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic diversity has the potential to impact the virus transmissibility and the escape from natural infection- or vaccine-elicited neutralizing antibodies. Here, representative samples from circulating SARS-CoV-2 in Colombia between January and April 2021, were processed for genome sequencing and lineage determination following the nanopore amplicon ARTIC network protocol and PANGOLIN pipeline. This strategy allowed us to identify the emergence of the B.1.621 lineage, considered a variant of interest (VOI) with the accumulation of several substitutions affecting the Spike protein, including the amino acid changes I95I, Y144T, Y145S and the insertion 146 N in the N-terminal domain, R346K, E484K and N501Y in the Receptor binding Domain (RBD) and P681H in the S1/S2 cleavage site of the Spike protein. The rapid increase in frequency and fixation in a relatively short time in Magdalena, Atlantico, Bolivar, Bogotá D.C, and Santander that were near the theoretical herd immunity suggests an epidemiologic impact. Further studies will be required to assess the biological and epidemiologic roles of the substitution pattern found in the B.1.621 lineage.</AbstractText><CopyrightInformation>Copyright © 2021 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laiton-Donato</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia. Electronic address: kdlaitond@unal.edu.co.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco-Muñoz</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia; Dirección General, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Álvarez-Díaz</LastName><ForeName>Diego A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Moreno</LastName><ForeName>Hector Alejandro</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usme-Ciro</LastName><ForeName>José A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia; Grupo de Parasitología. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prada</LastName><ForeName>Diego Andrés</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reales-González</LastName><ForeName>Jhonnatan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corchuelo</LastName><ForeName>Sheryll</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia; Ministerio de Salud y Protección Social de Colombia. Bogotá Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera-Sepúlveda</LastName><ForeName>María T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia; Dirección General, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naizaque</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia; Ministerio de Salud y Protección Social de Colombia. Bogotá Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santamaría</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia; Ministerio de Salud y Protección Social de Colombia. Bogotá Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia; Ministerio de Salud y Protección Social de Colombia. Bogotá Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz</LastName><ForeName>Juan Hernández</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Centro de Investigación en Salud para el Trópico - CIST, Facultad de Medicina, Universidad Cooperativa de Colombia, Santa Marta, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardona</LastName><ForeName>Andrés</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Investigación en Salud para el Trópico - CIST, Facultad de Medicina, Universidad Cooperativa de Colombia, Santa Marta, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malo</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Grupo de Morfología celular. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alvarado</LastName><ForeName>Franklin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Grupo de Morfología celular. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gómez</LastName><ForeName>Fernando Ruiz</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Laboratorio Genómico One Health. Universidad Nacional de Colombia. Medellín, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiesner</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez</LastName><ForeName>Martha Lucia Ospina</ForeName><Initials>MLO</Initials><AffiliationInfo><Affiliation>Dirección de Vigilancia en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercado-Reyes</LastName><ForeName>Marcela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia; Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Infect Genet Evol</MedlineTA><NlmUniqueID>101084138</NlmUniqueID><ISSNLinking>1567-1348</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="Y">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003105" MajorTopicYN="N" Type="Geographic">Colombia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="Y">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058974" MajorTopicYN="N">Phylogeography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Emergence</Keyword><Keyword MajorTopicYN="Y">Evolution</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword><Keyword MajorTopicYN="Y">Variant of interest (VOI)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>05</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>07</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>20</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34403832</ArticleId><ArticleId IdType="pii">S1567-1348(21)00336-1</ArticleId><ArticleId IdType="doi">10.1016/j.meegid.2021.105038</ArticleId><ArticleId IdType="pmc">PMC8364171</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>